<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200106046027N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-02-17</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Touch Therapy on Infant Growth</public_title>
      <acronym></acronym>
      <scientific_title>The effect of tactile stimulation of movement by the mother's physical growth of premature infants</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/44914</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Neonates are allocated in blocks of 4. Blocks are created by sealedenvelope website.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Prematurity.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Neonates in this group will receive 45 minutes daily massage in addition to standard care. The 45 minutes massage is delivered in three 15 minutes episodes for ten days. The 15 minutes massage are divided into three 5 minutes intervals. In the first and last phase, the neonate is placed in the prone position and touched with finger pulps of both hands. The following five areas are touched every minute: Twelve touch movements (one every 5 seconds) from the tip of the head downward to the face, neck and vice versa. Twelve touch movements (one every 5 seconds) from the back of the neck across the shoulders and vice versa. Twelve Touch movement (one every 5 seconds) from the upper back to the lower back and vice versa. Twelve Touch movement (one every 5 seconds) from the thighs down to the ankle and vice versa. Twelve touch movement (one every 5 seconds) from shoulder to wrist and vice versa. In the middle phase, the neonate is placed in the supine position and six passive extension-flexion movements (one every 10 seconds) are given in the following five areas: Right and left arms, Right foot and left legs, and both feet. The intervention will be performed between 7 a.m and 7 p.m. Intervention 2: Control group: Control group neonates will receive regular care of the ward.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
all collected deidentified data for primary and secondary outcome measures are going to be shared

When:
After publishing the study, data are going to be available

To whom:
Data are going to be available to all researchers and clinician irrespective to their employment sector

Conditions:
Permission are granted upon request for secondary and meta-analysis

Where to obtain:
Requests are gathered through principle researcher's e-mail address

How to obtain:
Upon verification of request and reason data are given in three month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hossein</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Taleghani Ave, No.20</address>
        <city>Ramsar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4815733971</zip>
        <telephone>+98 11 5522 6108</telephone>
        <email>firoozi.hosein@mazums.ac.ir</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hossein</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Taleghani Ave, No.20</address>
        <city>Ramsar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4815733971</zip>
        <telephone>+98 11 5522 6108</telephone>
        <email>firoozi.hosein@mazums.ac.ir</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>More than 5 days of age
gestational age &lt; 37 weeks
Birth weight between 1000 to 1500 grams
Exclusive breast feeding</inclusion_criteria>
      <agemin>5 days</agemin>
      <agemax>5 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Congenital anomalies
Mother with alcohol, cigarette or drug addiction
Prior history of surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P05</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Disorders of newborn related to slow fetal growth and fetal malnutrition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Neonates in this group will receive 45 minutes daily massage in addition to standard care. The 45 minutes massage is delivered in three 15 minutes episodes for ten days. The 15 minutes massage are divided into three 5 minutes intervals. In the first and last phase, the neonate is placed in the prone position and touched with finger pulps of both hands. The following five areas are touched every minute: Twelve touch movements (one every 5 seconds) from the tip of the head downward to the face, neck and vice versa. Twelve touch movements (one every 5 seconds) from the back of the neck across the shoulders and vice versa. Twelve Touch movement (one every 5 seconds) from the upper back to the lower back and vice versa. Twelve Touch movement (one every 5 seconds) from the thighs down to the ankle and vice versa. Twelve touch movement (one every 5 seconds) from shoulder to wrist and vice versa. In the middle phase, the neonate is placed in the supine position and six passive extension-flexion movements (one every 10 seconds) are given in the following five areas: Right and left arms, Right foot and left legs, and both feet. The intervention will be performed between 7 a.m and 7 p.m.</i_keyword>
      <i_keyword>Control group: Control group neonates will receive regular care of the ward.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Head Circumference. Timepoint: at birth, before intervention and 1, 2, 3 month after intervention. Method of measurement: Measuring tape.</prim_outcome>
      <prim_outcome>Height. Timepoint: at birth, before intervention and 1, 2, 3 month after intervention. Method of measurement: Measuring tape.</prim_outcome>
      <prim_outcome>Weight. Timepoint: at birth, before intervention and 1, 2, 3 month after intervention. Method of measurement: Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-02-28</approval_date>
        <contact_name>Ethics committee of mazandaran University of Medical Sciences</contact_name>
        <contact_address>No. 20, Taleghani Ave. Ramsar Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
